Related references
Note: Only part of the references are listed.The evolution of nerve growth factor inhibition in clinical medicine
Barton L. Wise et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial
Marc C. Hochberg et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Risk Factors for Canine Osteoarthritis and Its Predisposing Arthropathies: A Systematic Review
Katharine L. Anderson et al.
FRONTIERS IN VETERINARY SCIENCE (2020)
Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
Leslie Tive et al.
JOURNAL OF PAIN RESEARCH (2019)
Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats
Masataka Enomoto et al.
VETERINARY RECORD (2019)
Pharmacokinetics of monoclonal antibodies and Fc-fusion proteins
Liming Liu
PROTEIN & CELL (2018)
Effects of Monoclonal Antibodies against Nerve Growth Factor on Healthy Bone and Joint Tissues in Mice, Rats, and Monkeys: Histopathologic, Biomarker, and Microcomputed Tomographic Assessments
Kathryn E. Gropp et al.
TOXICOLOGIC PATHOLOGY (2018)
Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain
E. Niclas Jonsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation
Herve Lebrec et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2014)
Comparative functional characterization of canine IgG subclasses
Lisa M. Bergeron et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2014)
Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets
Pauline L. Martin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A multiple-dose toxicity study of tanezumab in cynomolgus monkeys
Mark Zorbas et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Targeting Nerve Growth Factor in Pain What is the Therapeutic Potential
Judy J. Watson et al.
BIODRUGS (2008)
An Update on Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Small Animals
Mark G. Papich
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2008)
Novel class of pain drugs based on antagonism of NGF
FF Hefti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Share Paper
